Search News
| 16.74 Delayed Data As of Sep 21 |  -0.72 / -4.12%Today’s Change | 5.87 Today|||52-Week Range 18.86 | +124.10% Year-to-Date |
| Previous close | 17.46 |
| Today’s open | 17.81 |
| Day’s range | 16.65 - 17.84 |
| Volume | 1,363,921 |
| Average volume (3 months) | 271,653 |
| Market cap | $520.1M |
| Earnings growth (last year) | +21.37% |
| Earnings growth (this year) | -38.77% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +32.86% |
| P/E ratio | NM |
| Price/Sales | 1.54 |
| Price/Book | 11.07 |
| Today’s change | Today’s % change | |
|---|---|---|
| ELOXEloxx Pharmaceutical... | +0.74 | +4.84% |
| SIGASIGA Technologies In... | +0.48 | +7.11% |
| FPRXFive Prime Therapeut... | -0.24 | -1.70% |
| PTEPolarityte Inc | -1.16 | -5.09% |
| Next reporting date | November 6, 2018 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $114.9M |
| Annual profit (last year) | -$43.6M |
| Net profit margin | -37.91% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert Bradley Gray |
Senior Vice President- Operations Mary Tedd Allen |
Corporate headquarters Seattle, Washington |
